Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02628314 · ClinicalTrials.gov registry record

Reliability of Pupil Response to Acute Pain

A clinical trial of Pain and Osteoarthritis, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
80
Enrollment target
1
Study location

NCT02628314 is a study of Pain and Osteoarthritis that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 80 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02628314, a study of Pain and Osteoarthritis, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test whether researchers can reliably measure the response pupils have when an acute painful stimulus is experienced. Changes in the size of the pupil of the eye can be an indicator of brain activity in a region of the brain that is important for feeling pain.

Conditions Studied

Study Locations (1)

North Carolina

  • Wake Forest Baptist Medical Center - Winston-Salem

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2015-08-04
Est. Completion 2026-12

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT02628314

The ClinicalTrials.gov registry entry for NCT02628314 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 0 interventions.

NCT02628314 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02628314 about?

NCT02628314 is a clinical study titled "Reliability of Pupil Response to Acute Pain". The purpose of this research study is to test whether researchers can reliably measure the response pupils have when an acute painful stimulus is experienced. Changes in the size of the pupil of the eye can be an indicator of brain activity in a region of the brain that is important for feeling pain...

What is the current status of trial NCT02628314?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2015-08-04. Estimated completion is 2026-12.

What conditions does trial NCT02628314 study?

This clinical trial studies the following conditions: Pain, Osteoarthritis.

Who is sponsoring clinical trial NCT02628314?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02628314 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.